NeuroPace, Inc. (NPCE)Healthcare | Medical Devices | Mountain View, United States | NasdaqGM
17.12 USD
+0.01
(0.058%)
⇧
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 7:07 a.m. EDT
NeuroPace presents a classic value trap scenario where the market has priced out the business entirely due to deteriorating fundamentals. The company is burning cash with negative operating margins and free cash flow, while revenue has contracted by 2%. Although the stock recently rallied off its lows, the underlying trajectory remains precarious; the balance sheet is fragile with debt exceeding cash reserves, and the return on equity is deeply negative. While the recent price action shows some life, the lack of sustainable growth and the heavy put positioning suggest that any rally is likely a contrarian bounce rather than a trend reversal. Without a clear path to profitability or a proven recovery in top-line growth, the investment case remains weak despite the low absolute price. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.052359 |
| AutoARIMA | 0.054535 |
| AutoETS | 0.054535 |
| AutoTheta | 0.070991 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 0.66 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.002 |
| Excess Kurtosis | 1.25 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 487.491 |
| Revenue per Share | 2.991 |
| Market Cap | 583,684,928 |
| Forward P/E | -57.59 |
| Beta | 1.89 |
| Profit Margins | -21.67% |
| Website | https://www.neuropace.com |
As of July 11, 2026, 7:07 a.m. EDT: Speculators are positioning defensively with heavy out-of-the-money put open interest at the $12.50 strike, suggesting a fear of a significant drop below current levels. Conversely, call activity is sparse and concentrated near the money, with notable open interest at distant $30 strikes in August, indicating a speculative hope for a massive rally rather than a measured bullish buildup. Implied volatility is elevated for near-term puts compared to calls, reflecting asymmetric downside anxiety.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.791623 |
| Address1 | 455 North Bernardo Avenue |
| All Time High | 27.38 |
| All Time Low | 1.22 |
| Ask | 21.73 |
| Ask Size | 2 |
| Audit Risk | 7 |
| Average Daily Volume10 Day | 227,420 |
| Average Daily Volume3 Month | 188,250 |
| Average Volume | 188,250 |
| Average Volume10Days | 227,420 |
| Beta | 1.889 |
| Bid | 12.37 |
| Bid Size | 2 |
| Board Risk | 9 |
| Book Value | 0.426 |
| City | Mountain View |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 17.12 |
| Current Ratio | 5.38 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 17.58 |
| Day Low | 16.95 |
| Debt To Equity | 487.491 |
| Display Name | NeuroPace |
| Earnings Call Timestamp End | 1,778,617,800 |
| Earnings Call Timestamp Start | 1,778,617,800 |
| Earnings Timestamp | 1,778,616,000 |
| Earnings Timestamp End | 1,786,478,400 |
| Earnings Timestamp Start | 1,786,478,400 |
| Ebitda | -16,510,000 |
| Ebitda Margins | -0.16588 |
| Enterprise To Ebitda | -36.352 |
| Enterprise To Revenue | 6.03 |
| Enterprise Value | 600,165,888 |
| Eps Current Year | -0.56015 |
| Eps Forward | -0.29725 |
| Eps Trailing Twelve Months | -0.65 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 16.3788 |
| Fifty Day Average Change | 0.7412014 |
| Fifty Day Average Change Percent | 0.04525371 |
| Fifty Two Week Change Percent | 79.1623 |
| Fifty Two Week High | 19.6 |
| Fifty Two Week High Change | -2.4799995 |
| Fifty Two Week High Change Percent | -0.12653059 |
| Fifty Two Week Low | 7.563 |
| Fifty Two Week Low Change | 9.557001 |
| Fifty Two Week Low Change Percent | 1.2636521 |
| Fifty Two Week Range | 7.563 - 19.6 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,619,098,200,000 |
| Float Shares | 23,292,847 |
| Forward Eps | -0.29725 |
| Forward P E | -57.59462 |
| Free Cashflow | -2,739,000 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 220 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.78294 |
| Gross Profits | 77,926,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.040359996 |
| Held Percent Institutions | 0.96282 |
| Implied Shares Outstanding | 34,093,745 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-04-22 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California. |
| Long Name | NeuroPace, Inc. |
| Market | us_market |
| Market Cap | 583,684,928 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_125322 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -21,565,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 583,684,914 |
| Number Of Analyst Opinions | 8 |
| Open | 17.22 |
| Operating Cashflow | -9,424,000 |
| Operating Margins | -0.25231 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | 650 237 2700 |
| Previous Close | 17.11 |
| Price Eps Current Year | -30.563242 |
| Price Hint | 2 |
| Price To Book | 40.187794 |
| Price To Sales Trailing12 Months | 5.864412 |
| Profit Margins | -0.21666999 |
| Quick Ratio | 4.253 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0100002 |
| Regular Market Change Percent | 0.0584467 |
| Regular Market Day High | 17.58 |
| Regular Market Day Low | 16.95 |
| Regular Market Day Range | 16.95 - 17.58 |
| Regular Market Open | 17.22 |
| Regular Market Previous Close | 17.11 |
| Regular Market Price | 17.12 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 96,510 |
| Return On Assets | -0.10018 |
| Return On Equity | -1.11381 |
| Revenue Growth | -0.02 |
| Revenue Per Share | 2.991 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 34,093,745 |
| Shares Percent Shares Out | 0.026400002 |
| Shares Short | 898,587 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 582,943 |
| Short Name | Neuropace, Inc. |
| Short Percent Of Float | 0.0304 |
| Short Ratio | 4.93 |
| Source Interval | 15 |
| State | CA |
| Symbol | NPCE |
| Target High Price | 22.0 |
| Target Low Price | 18.0 |
| Target Mean Price | 20.0 |
| Target Median Price | 20.0 |
| Total Cash | 53,981,000 |
| Total Cash Per Share | 1.583 |
| Total Debt | 70,462,000 |
| Total Revenue | 99,530,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.65 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 14.74015 |
| Two Hundred Day Average Change | 2.3798504 |
| Two Hundred Day Average Change Percent | 0.1614536 |
| Type Disp | Equity |
| Volume | 96,510 |
| Website | https://www.neuropace.com |
| Zip | 94,043 |